Medicine

DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates+

21st September 2007
pedro cahn DUET 1 and 2 Trials: TMC 125 has Superior Virologic and Immunologic Response Rates
Pedro Cahn

REFERENCE: Abstract H-717, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
PEDRO CAHN, Juan A. Fernández Hospital, Buenos Aires
Etravirine provides a chance to rescue patients who are failing non-nucleoside regimens according to 24-week

…

Read More+

Hospital Hand Hygiene Program Successfully Rolled Out+

21st September 2007
lindsay grayson Hospital Hand Hygiene Program Successfully Rolled Out
Lindsay Grayson

REFERENCE: Abstract K-1374, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
LINDSAY GRAYSON, Austin Hospital, Victoria, Australia
A hand hygiene campaign implemented in six hospitals in Victoria, Australia has saved lives from MRSA, and

…

Read More+

BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns+

21st September 2007
Jennifer Lavrrar, Jane Hata, Jeanette Block
jane hata team BORIS: A. baumanni Highly Resistant β Lactamase and Varying Susceptibility Patterns
Jennifer Lavrrar, Jane Hata, Jeanette Block

REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JANE HATA, bioMéríeux Inc, Durham
Reports from the BORIS study call for ongoing surveillance of multi-drug resistant Acinetobacter

…

Read More+

Entecavir for Hepatitis B Linked to HIV Resistance+

20th September 2007
Moira McMahon
moira mcmahon Entecavir for Hepatitis B Linked to HIV Resistance
Moira McMahon

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
MOIRA MCMAHON, Johns Hopkins University, Baltimore
The hepatitis B drug entecavir appears to select for a drug resistant HIV mutation – and this has implications for

…

Read More+

Monoclonal Antibody to Help Treat HIV?+

20th September 2007
Jeffrey Jacobson
jeffrey jacobson Monoclonal Antibody to Help Treat HIV?
Jeffrey Jacobson

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JEFFREY JACOBSON, Drexel University College of Medicine, Philadelphia
Could a monoclonal antibody have a role to play in HIV treatment? Early data on the PRO 140

…

Read More+

Maraviroc for HIV: Responses at 48 Weeks+

20th September 2007
jacob lalezari Maraviroc for HIV: Responses at 48 Weeks
Jacob Lalezari

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JACOB LALEZARI, Quest Clinical Research, San Francisco
Maraviroc could be a useful new drug for the treatment of some HIV infections, according to Jacob Lalezari of

…

Read More+

Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses+

19th September 2007
georg harter Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses
Georg Härter

REFERENCE:47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
GEORG HÄRTER, University Hospital, Ulm
For patients with multiple myeloma being treated with the proteasome inhibitor bortezomib, doctor’s should be wary of viral reactivation – and

…

Read More+

Nosocomial Clostridrium Difficile: Reduce by Cleaning with Household Bleach+

19th September 2007
donna hacek Nosocomial Clostridrium Difficile: Reduce by Cleaning with Household Bleach
Donna Hacek

REFERENCE: Slide Session 42 K-608, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
DONNA HACEK, Evanston Hospital, Evanston Illinois
Thorough, all surface bleach cleaning helps to achieve a significant and sustained reduction in nosocomial

…

Read More+

MRSA: Fight Superbug Using Hydrogen Peroxide Vapour+

18th September 2007
jon otter MRSA: Fight Superbug Using Hydrogen Peroxide Vapour
Jon Otter

REFERENCE: Poster Session 033 K-464, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JON OTTER, Bioquell Ltd, Andover UK
An investigation looking at hydrogen peroxide vapour for sterilisation in hospital areas at risk of

…

Read More+

Drug Eluting Stents, Bare Metal Stents: No Survival Difference+

2nd September 2007
stefan james Drug Eluting Stents, Bare Metal Stents: No Survival Difference
Stefan James
raymond gibbons Drug Eluting Stents, Bare Metal Stents: No Survival Difference
Raymond Gibbons

REFERENCE: Hot Line 1 Sunday 11:00 2 Sept, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
STEFAN JAMES, Uppsala Clinical Research Centre, Sweden
COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester MN
Another year’s results of

…

Read More+

Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study+

2nd September 2007
stephen macmahon Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study
Stephen MacMahon
raymond gibbons Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study
Raymond Gibbons

REFERENCE: Abstract 312 Hot Line 1 Sunday, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
STEPHEN MACMAHON, The George Institute, University of Sydney
COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester MN
The randomised placebo controlled

…

Read More+

Lifestyle and Heart Disease in Europe: A Growing Problem+

2nd September 2007
david wood Lifestyle and Heart Disease in Europe: A Growing Problem
David Wood

REFERENCE: European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria; Abstract 316
DAVID WOOD, Charing Cross Hospital, London
Among 8000 coronary patients in 9 European countries, smoking prevalence hasn’t changed over the last 12 years, and obesity

…

Read More+